Cargando…
The global impact and cost-effectiveness of a melioidosis vaccine
BACKGROUND: Every year, 90,000 people may die from melioidosis. Vaccine candidates have not proceeded past animal studies, partly due to uncertainty around the potential market size. This study aims to estimate the potential impact, cost-effectiveness and market size for melioidosis vaccines. METHOD...
Autores principales: | Luangasanatip, Nantasit, Flasche, Stefan, Dance, David A. B., Limmathurotsakul, Direk, Currie, Bart J., Mukhopadhyay, Chiranjay, Atkins, Tim, Titball, Richard, Jit, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610909/ https://www.ncbi.nlm.nih.gov/pubmed/31272431 http://dx.doi.org/10.1186/s12916-019-1358-x |
Ejemplares similares
-
Global Burden and Challenges of Melioidosis
por: Dance, David AB, et al.
Publicado: (2018) -
Clinical Definitions of Melioidosis
por: Cheng, Allen C., et al.
Publicado: (2013) -
Melioidosis: The hazards of incomplete peer-review
por: Limmathurotsakul, Direk, et al.
Publicado: (2019) -
Emergence of Melioidosis in Indonesia
por: Tauran, Patricia M., et al.
Publicado: (2015) -
Cost-effectiveness analysis of parenteral antimicrobials for acute melioidosis in Thailand
por: Hantrakun, Viriya, et al.
Publicado: (2015)